Cargando…
Bispecific antibodies: design, therapy, perspectives
Antibodies (Abs) containing two different antigen-binding sites in one molecule are called bispecific. Bispecific Abs (BsAbs) were first described in the 1960s, the first monoclonal BsAbs were generated in the 1980s by hybridoma technology, and the first article describing the therapeutic use of BsA...
Autores principales: | Sedykh, Sergey E, Prinz, Victor V, Buneva, Valentina N, Nevinsky, Georgy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784585/ https://www.ncbi.nlm.nih.gov/pubmed/29403265 http://dx.doi.org/10.2147/DDDT.S151282 |
Ejemplares similares
-
Human Milk IgGs Contain Various Combinations of Different Antigen-Binding Sites Resulting in Multiple Variants of their Bispecificity
por: Sedykh, Sergey E., et al.
Publicado: (2012) -
Human Milk sIgA Molecules Contain Various Combinations of Different Antigen-Binding Sites Resulting in a Multiple Binding Specificity of Antibodies and Enzymatic Activities of Abzymes
por: Sedykh, Sergey E., et al.
Publicado: (2012) -
Natural Catalytic Antibodies in Norm, Autoimmune, Viral, and Bacterial Diseases
por: Nevinsky, Georgy A., et al.
Publicado: (2010) -
HIV-Infected Patients: Cross Site-Specific Hydrolysis of H3 and H4 Histones and Myelin Basic Protein with Antibodies against These Three Proteins
por: Baranova, Svetlana V., et al.
Publicado: (2021) -
Milk Exosomes: Perspective Agents for Anticancer Drug Delivery
por: Sedykh, Sergey, et al.
Publicado: (2020)